DGAP-News

MeVis Medical Solutions AG: Preliminary figures 2013: MeVis forecast fully met / First guidance for 2014 - Seite 2

accordance with the new IFRS 11, we will no longer consolidate our joint
venture with Siemens MeVis Breast Care proportionately but under the
at-equity method, with corresponding effects on revenues, costs and
liquidity among other things. Based on this, for 2014 we expect revenues
between EUR 12.0 and EUR 12.5 m. This is a slight decrease compared to the
extremely positive year 2013, for which, on a comparable basis, revenues of
EUR 12.8 m would have been reported. We expect an EBIT of between EUR 3.0
and EUR 3.5 m, which is lower than the adjusted previous year's figure of
EUR 4.4 m due to the slight decline in revenues and a selective increase of
resources for development and sales. Liquidity should increase again in
2014 and at the end of 2014 we anticipate a liquidity between EUR 15.0 and
EUR 16.0 m compared with a value of EUR 13.4 m at the end of 2013 on a
comparable basis." said Dr. Robert Hannemann, CFO of MeVis Medical
Solutions AG.

"Following the announcement of our industrial customer Hologic in January
of this year, that in the medium-term an altered form of cooperation with
MeVis is sought, we are very pleased that, a few days ago, we were able to
extend the current contract until the end of 2015 at the existing terms.
Apart from that, MeVis will continue to strongly focus on the development
and implementation of measures designed to generate future sales growth. We
will utilize and expand our clinical and technological expertise in order
to hold a prominent market position in our core fields breast, lung and
liver imaging. Our goal for the financial year 2014 is to expand our
industrial customers segment and to broaden the marketing of our MeVis
Online Services." added Marcus Kirchhoff, CEO of MeVis Medical Solutions
AG.

The final consolidated financial statement and the group management report
will be published on April 24, 2014.


End of Corporate News

---------------------------------------------------------------------

05.03.2014 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language: English
Company: MeVis Medical Solutions AG
Caroline-Herschel-Str. 1
28359 Bremen
Germany
Phone: [phone]
Fax: [phone]
E-mail: [e-mail]
Internet: http://www.mevis.de
ISIN: DE000A0LBFE4
WKN: A0LBFE
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, München, Stuttgart


End of News DGAP News-Service
---------------------------------------------------------------------
255718 05.03.2014